Company Filing History:
Years Active: 2019-2025
Title: Innovations and Contributions of Inventor Jennifer Bordeaux
Introduction
Jennifer Bordeaux is a prominent inventor based in Carlsbad, California, known for her significant contributions to the field of biomedical research. With a total of 11 patents to her name, she has made remarkable advancements in therapies targeting various diseases. Her work focuses on innovative methods and compositions that enhance treatment efficacy for patients.
Latest Patents
Among her latest patents are groundbreaking therapies related to CD20 and CD22, as well as combination therapies utilizing a CD19 chimeric antigen receptor (CAR)-expressing cell. These inventions provide compositions and methods for treating diseases associated with the expression of CD19. The approach involves administering a recombinant T cell that comprises the CD19 CAR, in conjunction with one or more B-cell inhibitors. Additionally, her patents feature novel antigen binding domains and CAR molecules directed to CD20 and CD22, which can be used as monotherapies or in combination therapies. Another notable invention is a computer method and system for deriving cell-to-cell spatial proximities, which scores tumor tissue samples from cancer patients. This scoring system assesses the nearness between cells expressing different biomarkers, providing insights into the likelihood of a positive response to immunotherapy.
Career Highlights
Jennifer has worked with esteemed organizations such as Novartis and the University of Pennsylvania. Her experience in these institutions has allowed her to collaborate on various innovative projects that push the boundaries of medical science.
Collaborations
Throughout her career, Jennifer has collaborated with notable professionals, including Brian Little and Naveen Kumar Dakappagari. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Jennifer Bordeaux's contributions to the field of biomedical research through her innovative patents and collaborations highlight her as a leading inventor. Her work continues to pave the way for new therapies that can significantly impact patient care and treatment outcomes.